Leukocyte Immunoglobulin-like Receptors in Cutaneous Host Defense
皮肤宿主防御中的白细胞免疫球蛋白样受体
基本信息
- 批准号:7179241
- 负责人:
- 金额:$ 10.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-02-05 至 2010-11-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAllogenicAntigen PresentationAntigen-Presenting CellsAutoantigensBacteriaBloodCD14 geneCD80 geneCell MaturationCell surfaceCellsCellular ImmunologyClinicalCommitCommunicable DiseasesConfocal MicroscopyCutaneousDataDendritic CellsDermatologicDermatologyDeveloped CountriesDeveloping CountriesDevelopmentDiseaseDoctor of MedicineDoctor of PhilosophyEconomic BurdenFamilyFamily memberFellowshipFigs - dietaryFrequenciesGene Expression Microarray AnalysisGenesGoalsHistocompatibility Antigens Class IIHost DefenseHost Defense MechanismITGAX geneImmuneImmune ToleranceImmune responseImmune systemImmunityImmunoglobulinsImmunohistochemistryImmunotherapyInfectionInterleukin-10Interleukin-12InvestigationLabelLaboratoriesLeadLepromatous LeprosyLeprosyLesionLeukocytesLigandsMajor Histocompatibility ComplexMediatingMedicineMemoryMentorsMessenger RNAModelingMonoclonal AntibodiesMycobacterium lepraeNatural ImmunityOutcomePatientsPatternPopulationPrincipal InvestigatorProductionProgram DevelopmentProtein IsoformsPrunella vulgarisReceptor ActivationRegulationResearchResearch PersonnelResidenciesRoleSkinStructureT memory cellT-Cell ActivationT-LymphocyteTestingToll-like receptorsTrainingTraining ProgramsUp-RegulationWorkantimicrobialcareercell mediated immune responsecell typecomparativecrosslinkcytokinehealth economicsimmunoregulationinsightkillingsmacrophagemembermonocytenovelpathogenperipheral bloodprogramsreceptorreceptor expressionresearch studyresponseskills
项目摘要
DESCRIPTION (provided by applicant):
This proposal describes a 5 year training program for the development of an academic career in Dermatology. The principal investigator has completed over 90% of her structured residency training in Dermatology at UCLA, and is currently expanding her scientific skills through a program committed to promoting careers in academic medicine by integrating dermatology residency training with a two-year protected postdoctoral research fellowship. This program will promote the command of cellular immunology, as applied to the dermatologic infectious disease, leprosy. Dr. Robert Modlin will mentor the principal investigator's scientific development and is a recognized leader in the field of leprosy, with current ongoing studies in his laboratory involving the mechanisms of host defense and innate immunity in skin, both of which are relevant to this proposal. The principal investigator's long-term career goal is to be an independent investigator in academic dermatology with her own laboratory. Research will focus on using leprosy, a disease with a spectrum of clinical outcomes depending on the host immune response, to study the role of a novel family of receptors, the leukocyte immunoglobulin-like receptors (LILRs) in immune dysregulation. Recent work in Dr. Modlin's laboratory identified an increased expression of LILR family members in the progressive lepromatous form of leprosy compared to the selfhealing tuberculoid form by gene profiling studies. The proposed experiments will entail further analysis of the expression of LILRs in leprosy as well as investigation of the function of the LILR family members. The specific aims include: 1) identifying the cell type(s) in leprosy lesions that express particular LILR family members, 2) evaluating the roles of LILRs in regulation of innate immunity, and 3) investigating whether LILR activation affects adaptive immune responses. Multidrug therapy still has not eradicated leprosy, affecting approximately one million people worldwide still poses a significant health and economic burden on developing countries. The insights gained from the study of LILRs, found at increased levels in lepromatous leprosy, will help broaden our understanding of immunoregulation of the innate and adaptive immune systems and may lead to the development of immunotherapies to treat this and other infectious diseases.
描述(由申请人提供):
该提案描述了一个为期5年的培训计划,以发展皮肤科的学术生涯。主要研究者已经完成了她在加州大学洛杉矶分校皮肤科的结构化住院医师培训的90%以上,目前正在通过一项致力于通过将皮肤科住院医师培训与为期两年的受保护博士后研究奖学金相结合来促进学术医学事业的计划来扩展她的科学技能。该计划将促进细胞免疫学的命令,适用于皮肤传染病,麻风病。Robert Modlin博士将指导主要研究者的科学发展,他是麻风病领域公认的领导者,目前正在他的实验室进行的研究涉及宿主防御和皮肤先天免疫的机制,两者都与本提案有关。首席研究员的长期职业目标是成为一名独立的学术皮肤病学研究员,拥有自己的实验室。研究将侧重于使用麻风病,一种具有取决于宿主免疫反应的一系列临床结果的疾病,来研究一种新的受体家族,即白细胞免疫球蛋白样受体(LILR)在免疫失调中的作用。Modlin博士实验室最近的工作通过基因分析研究发现,与自愈性结核样形式相比,LILR家族成员在进行性麻风瘤型中的表达增加。拟议的实验将需要进一步分析LILR在麻风病中的表达,以及LILR家族成员的功能调查。具体目标包括:1)鉴定麻风病病灶中表达特定LILR家族成员的细胞类型,2)评估LILR在先天免疫调节中的作用,和3)研究LILR活化是否影响适应性免疫应答。 多种药物疗法仍然没有根除麻风病,全世界大约有100万人感染麻风病,仍然对发展中国家造成重大的健康和经济负担。从LILR研究中获得的见解,在麻风瘤型麻风中发现的水平增加,将有助于扩大我们对先天和适应性免疫系统免疫调节的理解,并可能导致免疫疗法的发展来治疗这种疾病和其他传染病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Delphine J Lee其他文献
Delphine J Lee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Delphine J Lee', 18)}}的其他基金
Mechanisms of Innate and Acquired Host Defense and Tissue Injury in Skin
先天性和后天性宿主防御和皮肤组织损伤的机制
- 批准号:
8101186 - 财政年份:2010
- 资助金额:
$ 10.61万 - 项目类别:
Mechanisms of Innate and Acquired Host Defense and Tissue Injury in Skin
先天性和后天性宿主防御和皮肤组织损伤的机制
- 批准号:
8500211 - 财政年份:2010
- 资助金额:
$ 10.61万 - 项目类别:
Mechanisms of Innate and Acquired Host Defense and Tissue Injury in Skin
先天性和后天性宿主防御和皮肤组织损伤的机制
- 批准号:
7992592 - 财政年份:2010
- 资助金额:
$ 10.61万 - 项目类别:
Mechanisms of Innate and Acquired Host Defense and Tissue Injury in Skin
先天性和后天性宿主防御和皮肤组织损伤的机制
- 批准号:
8274442 - 财政年份:2010
- 资助金额:
$ 10.61万 - 项目类别:
Mechanisms of Innate and Acquired Host Defense and Tissue Injury in Skin
先天性和后天性宿主防御和皮肤组织损伤的机制
- 批准号:
8668901 - 财政年份:2010
- 资助金额:
$ 10.61万 - 项目类别:
Mechanisms of Innate and Acquired Host Defense and Tissue Injury in Skin
先天性和后天性宿主防御和皮肤组织损伤的机制
- 批准号:
8262767 - 财政年份:2010
- 资助金额:
$ 10.61万 - 项目类别:
Leukocyte Immunoglobulin-like Receptors in Cutaneous Host Defense
皮肤宿主防御中的白细胞免疫球蛋白样受体
- 批准号:
7348380 - 财政年份:2006
- 资助金额:
$ 10.61万 - 项目类别:
Leukocyte Immunoglobulin-like Receptors in Cutaneous Host Defense
皮肤宿主防御中的白细胞免疫球蛋白样受体
- 批准号:
7015759 - 财政年份:2006
- 资助金额:
$ 10.61万 - 项目类别:
Leukocyte Immunoglobulin-like Receptors in Cutaneous Host Defense
皮肤宿主防御中的白细胞免疫球蛋白样受体
- 批准号:
7579773 - 财政年份:2006
- 资助金额:
$ 10.61万 - 项目类别:
Leukocyte Immunoglobulin-like Receptors in Cutaneous Host Defense
皮肤宿主防御中的白细胞免疫球蛋白样受体
- 批准号:
7741702 - 财政年份:2006
- 资助金额:
$ 10.61万 - 项目类别:
相似海外基金
HLA-homozygous iPSC-cardiomyocytE Aggregate manufacturing technoLogies for allogenic cell therapy to the heart (HEAL)
HLA-纯合 iPSC-心肌细胞 用于心脏同种异体细胞治疗 (HEAL) 的聚集体制造技术
- 批准号:
10039902 - 财政年份:2022
- 资助金额:
$ 10.61万 - 项目类别:
EU-Funded
Evaluation of the efficacy of LAT1 inhibitor to tumor stroma and immunity in an allogenic mouse model of colon cancer having abundant stroma.
在具有丰富基质的同种异体结肠癌小鼠模型中评估 LAT1 抑制剂对肿瘤基质和免疫的功效。
- 批准号:
21K15925 - 财政年份:2021
- 资助金额:
$ 10.61万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mechanism of kidney injury associated with graft-versus-host disease after allogenic stem cell transplantation
同种异体干细胞移植后移植物抗宿主病相关肾损伤的机制
- 批准号:
21K08410 - 财政年份:2021
- 资助金额:
$ 10.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Clarification of the origin and maintenance mechanisms of junctional epithelium and identification of its stem cells using allogenic tooth germ transplantation
阐明交界上皮的起源和维持机制并利用同种异体牙胚移植鉴定其干细胞
- 批准号:
20K21672 - 财政年份:2020
- 资助金额:
$ 10.61万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
The study about the allogenic MSCs transplantation to the cardiac disease models.
同种异体间充质干细胞移植至心脏病模型的研究。
- 批准号:
18K16395 - 财政年份:2018
- 资助金额:
$ 10.61万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Artificial nerves containing allogenic basal lamellae scaffold and bone marrow derived stem cells
含有同种异体基底板层支架和骨髓干细胞的人工神经
- 批准号:
17K10951 - 财政年份:2017
- 资助金额:
$ 10.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of HSP90-alpha in preserving immunoprivilege of allogenic mesenchymal stem cells in the ischemic heart
HSP90-α 在保护缺血心脏同种异体间充质干细胞免疫特权中的作用
- 批准号:
370541 - 财政年份:2017
- 资助金额:
$ 10.61万 - 项目类别:
Operating Grants
Attempt to Prefabricate Vascularized Allogenic Bone in Recipient -Use of Cultured Bone Marrow Cells-
尝试在受者体内预制血管化的同种异体骨 - 使用培养的骨髓细胞 -
- 批准号:
16K10863 - 财政年份:2016
- 资助金额:
$ 10.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Allogenic micobiota-reconstitution (AMR) for the treatment of patients with diarhea-predominant irritable bowel syndrome (IBS-D) - the AMIRA trial
同种异体微生物群重建 (AMR) 用于治疗腹泻型肠易激综合征 (IBS-D) 患者 - AMIRA 试验
- 批准号:
276706135 - 财政年份:2015
- 资助金额:
$ 10.61万 - 项目类别:
Clinical Trials
Induction of thyme epithelial cells from iPS cells and application to allogenic transplantation
iPS细胞诱导百里香上皮细胞及其在同种异体移植中的应用
- 批准号:
15H04915 - 财政年份:2015
- 资助金额:
$ 10.61万 - 项目类别:
Grant-in-Aid for Scientific Research (B)